Evidence map›Paper›PMID 33863360›Full record

ArticleJournal of experimental & clinical cancer research : CR2021

Correction to: Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma.

Yan Chen, Zhonghu Li, Mengyun Zhang, Bo Wang, Jiaxin Ye, Yang Zhang, Di Tang, Dandan Ma, Weidong Jin, Xiaowu Li and 1 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Heliyon · 2023
    Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yan Chen *Hepatobiliary Surgery Institute, Southwest Hospital, Army Medical University, Chongqing, China.
Zhonghu Li *Dept. general surgery, Central Theater Command General Hospital of PLA, Hubei, China.
Mengyun Zhang *Department Rheumatology of Integrated Traditional Chinese and Western Medicine, Central Theater Command general hospital of PLA, Hubei, China.
Bo WangDept. general surgery, Central Theater Command General Hospital of PLA, Hubei, China.
Jiaxin YeDept. general surgery, Central Theater Command General Hospital of PLA, Hubei, China.
Yang ZhangDept. general surgery, Central Theater Command General Hospital of PLA, Hubei, China.
Di TangDept. general surgery, Central Theater Command General Hospital of PLA, Hubei, China.
Dandan MaDept. general surgery, Central Theater Command General Hospital of PLA, Hubei, China.
Weidong JinDept. general surgery, Central Theater Command General Hospital of PLA, Hubei, China.
Xiaowu LiHepatobiliary Surgery Institute, Southwest Hospital, Army Medical University, Chongqing, China.
Shuguang WangHepatobiliary Surgery Institute, Southwest Hospital, Army Medical University, Chongqing, China. sgwangxnyy@sina.com.
Wuhan General Hospital of Guangzhou · CNArmy Medical University · CNShenzhen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33863360
PMCPMC8052734
OpenAlexW3190916607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.